NewLimit has raised an additional $45M from Lilly, Duke University, Section 32, & Abstract on a $1.62B cap
July // August 2025 Progress Update
Matthew Breyer and Benjamin Humphreys have joined our Scientific Advisory Board
May // June 2025 – Progress Update
NewLimit raises $130 million Series B led by Kleiner Perkins alongside NFDG, Khosla Ventures, Human Capital and others
2025 NewLimit Progress Update
January // February 2025 Progress Update
2024 Year in Review
